MedReleaf announced it obtained certification under the EU GMP standards for its facility in Germany, allowing it to complete exports of medical cannabis into the country.
MedReleaf (TSX:LEAF) announced it obtained certification under the European Medical Agency’s Good Manufacturing Practices (EU GMP) standards for its Markham facility, allowing it to complete exports of medical cannabis into Germany.
As quoted in the press release:
“With the completion of our first shipment to Germany and ongoing shipments scheduled, MedReleaf is already among the leading exporters of cannabis to the European Union,” said Neil Closner, CEO of MedReleaf. “Demand for medical cannabis in Germany far exceeds available supply, and with production, processes and requisite certifications for commercial scale exports in place, we are well positioned to expand our footprint in the EU and drive expanded access for patients around the world to MedReleaf’s premium medical cannabis products.”
Cannamedical Pharma is a pioneer in the German medical cannabis industry and a leading medical cannabis distributor to pharmacies in Germany with the fastest growing network of more than 2,100 cannabis distributing pharmacies across the country.